(Q33370034)

26 July 2017

title

Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity (English)

1 reference

26 July 2017

Borrows R

1

1 reference

26 July 2017

Chusney G

2

1 reference

26 July 2017

Loucaidou M

3

1 reference

26 July 2017

James A

4

1 reference

26 July 2017

Lee J

5

1 reference

26 July 2017

Tromp JV

6

1 reference

26 July 2017

Owen J

7

1 reference

26 July 2017

Cairns T

8

1 reference

26 July 2017

Griffith M

9

1 reference

26 July 2017

Hakim N

10

1 reference

26 July 2017

McLean A

11

1 reference

26 July 2017

Palmer A

12

1 reference

26 July 2017

Papalois V

13

1 reference

26 July 2017

Taube D

14

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

American Journal of Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

6

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

121-128

1 reference

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Drug monitoring of mycophenolic acid in the early period after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Acyl glucuronide drug metabolites: toxicological and analytical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01151.X

10.1111/J.1600-6143.2005.01151.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference